Bliss GVS Pharma Investor Relations Material
Latest events
Q1 25/26
30 Jul, 2025
Q4 24/25
2 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bliss GVS Pharma Limited
Access all reports
Bliss GVS Pharma Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company offers dosage forms including suppositories, tablets, capsules, dry syrups, creams, and ointments across therapeutic segments such as anti-malarial, dermatology, gynecology, and anti-infectives. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
506197
Country
🇮🇳 India